info@cagcolloids.com    +86-198 8490 8291
Menu
Products and Ingredients
FAQs
Nature Refined, Quality Defined
Green Science for better living
Home/

FAQs

Pharmaceutical Grade Gellan Gum: The Leading Vehicle for In-Situ Gelling and Controlled-Release Formulations

Pharmaceutical Grade Gellan Gum: The Leading Vehicle for In-Situ Gelling and Controlled-Release Formulations

The application of gellan gum within the pharmaceutical industry is experiencing exponential growth, driven primarily by its unique ion-sensitive in-situ gelling characteristics. For advanced drug delivery systems, this biomaterial offers unparalleled structural control and predictability.

Advanced Applications in Ophthalmic Delivery Systems

Ophthalmic drug delivery frequently suffers from low bioavailability due to rapid nasolacrimal drainage and physiological tear turnover. Eye drops formulated with pharmaceutical-grade low acyl gellan gum directly overcome this limitation through a localized phase transition mechanism:

Fig The pharmaceutical grade gellan gum for eye drops 

  • Ion-Triggered Phase Transition: Upon instillation into the conjunctival sac, the fluid low acyl gellan gum solution reacts instantaneously with the ambient monovalent and divalent cations—specifically sodium ($Na^{+}$) and calcium ($Ca^{2+}$)—present naturally in human tear fluid.

  • Prolonged Precorneal Retention: This ionic interaction triggers an immediate, highly localized gelation on the ocular surface, transforming the liquid drop into a thin, biocompatible, and non-blurring mucoadhesive hydrogel shield.

  • Enhanced Bioavailability: By establishing this protective matrix, gellan gum significantly prolongs precorneal retention time, reducing precorneal drug elimination and boosting ocular bioavailability by more than three times compared to conventional aqueous eye drops.

A Certified Partner for Pharmaceutical Excipient Solutions

As a primary, source-level manufacturer, we produce high-purity pharmaceutical-grade gellan gum under rigorous quality standards. Our product features exceptionally low endotoxin levels, tight molecular weight control, and optimal batch-to-batch rheological consistency to satisfy global regulatory compliance for ophthalmic and oral drug delivery systems. Contact our pharmaceutical technical department to request material safety data sheets, regulatory documentation, and verification samples for your laboratory trials.

Need support on product development?